136 related articles for article (PubMed ID: 8016407)
1. Cholecystokinin- and dexfenfluramine-induced anorexia compared using devazepide and c-fos expression in the rat brain.
Li BH; Rowland NE
Regul Pept; 1994 Mar; 50(3):223-33. PubMed ID: 8016407
[TBL] [Abstract][Full Text] [Related]
2. Effects of vagotomy on cholecystokinin- and dexfenfluramine-induced Fos-like immunoreactivity in the rat brain.
Li BH; Rowland NE
Brain Res Bull; 1995; 37(6):589-93. PubMed ID: 7670882
[TBL] [Abstract][Full Text] [Related]
3. Reversal of dexfenfluramine-induced anorexia and c-Fos/c-Jun expression by lesion in the lateral parabrachial nucleus.
Li BH; Spector AC; Rowland NE
Brain Res; 1994 Mar; 640(1-2):255-67. PubMed ID: 8004454
[TBL] [Abstract][Full Text] [Related]
4. Medial versus lateral parabrachial nucleus lesions in the rat: effects on cholecystokinin- and D-fenfluramine-induced anorexia.
Trifunovic R; Reilly S
Brain Res; 2001 Mar; 894(2):288-96. PubMed ID: 11251203
[TBL] [Abstract][Full Text] [Related]
5. Reciprocal interaction of 5-hydroxytryptamine and cholecystokinin in the control of feeding patterns in rats.
Grignaschi G; Mantelli B; Fracasso C; Anelli M; Caccia S; Samanin R
Br J Pharmacol; 1993 Jun; 109(2):491-4. PubMed ID: 8358548
[TBL] [Abstract][Full Text] [Related]
6. Pathways of Fos expression in locus ceruleus, dorsal vagal complex, and PVN in response to intestinal lipid.
Mönnikes H; Lauer G; Bauer C; Tebbe J; Zittel TT; Arnold R
Am J Physiol; 1997 Dec; 273(6):R2059-71. PubMed ID: 9435662
[TBL] [Abstract][Full Text] [Related]
7. The CCK-A receptor antagonist, devazepide, blocks the anorectic action of CCK but not peripheral serotonin in rats.
Eberle-Wang K; Simansky KJ
Pharmacol Biochem Behav; 1992 Nov; 43(3):943-7. PubMed ID: 1448490
[TBL] [Abstract][Full Text] [Related]
8. Duodenal loading with glucose induces fos expression in rat brain: selective blockade by devazepide.
Wang L; Cardin S; Martínez V; Taché Y; Lloyd KC
Am J Physiol; 1999 Sep; 277(3):R667-74. PubMed ID: 10484482
[TBL] [Abstract][Full Text] [Related]
9. Cross tolerance between anorectic action and induction of Fos-ir with dexfenfluramine and 5HT1B/2C agonists in rats.
Rowland NE; Robertson K; Lo J; Rema E
Psychopharmacology (Berl); 2001 Jun; 156(1):108-14. PubMed ID: 11465628
[TBL] [Abstract][Full Text] [Related]
10. Involvement of cholecystokinin receptor types in pathways controlling oxytocin secretion.
Luckman SM; Hamamura M; Antonijevic I; Dye S; Leng G
Br J Pharmacol; 1993 Sep; 110(1):378-84. PubMed ID: 8220899
[TBL] [Abstract][Full Text] [Related]
11. Effect of repeated administration of dexfenfluramine on feeding and brain Fos in mice.
Rowland NE; Robertson K; Green DJ
Physiol Behav; 2003 Feb; 78(2):295-301. PubMed ID: 12576128
[TBL] [Abstract][Full Text] [Related]
12. Reversal of the anorectic effect of (+)-fenfluramine in the rat by the selective cholecystokinin receptor antagonist MK-329.
Cooper SJ; Dourish CT; Barber DJ
Br J Pharmacol; 1990 Jan; 99(1):65-70. PubMed ID: 2331576
[TBL] [Abstract][Full Text] [Related]
13. Effect of chronic dexfenfluramine on Fos in rat brain.
Li BH; Rowland NE
Brain Res; 1996 Jul; 728(2):188-92. PubMed ID: 8864481
[TBL] [Abstract][Full Text] [Related]
14. Tolerance to the anorectic effect of dexfenfluramine in rats: role of serotonin, cholecystokinin, and neuropeptide Y.
Rowland NE
Physiol Behav; 1994 Feb; 55(2):201-7. PubMed ID: 8153156
[TBL] [Abstract][Full Text] [Related]
15. Area postrema and the anorectic actions of dexfenfluramine and amylin.
Rowland NE; Richmond RM
Brain Res; 1999 Feb; 820(1-2):86-91. PubMed ID: 10023034
[TBL] [Abstract][Full Text] [Related]
16. Dexfenfluramine induces Fos-like immunoreactivity in discrete brain regions in rats.
Li BH; Rowland NE
Brain Res Bull; 1993; 31(1-2):43-8. PubMed ID: 8453494
[TBL] [Abstract][Full Text] [Related]
17. Meal-induced c-fos expression in brain stem is not dependent on cholecystokinin release.
Fraser KA; Davison JS
Am J Physiol; 1993 Jul; 265(1 Pt 2):R235-9. PubMed ID: 8342693
[TBL] [Abstract][Full Text] [Related]
18. The subfornical organ: a novel site of action of cholecystokinin.
Ahmed AS; Dai L; Ho W; Ferguson AV; Sharkey KA
Am J Physiol Regul Integr Comp Physiol; 2014 Mar; 306(5):R363-73. PubMed ID: 24430886
[TBL] [Abstract][Full Text] [Related]
19. Intracerebroventricular cholecystokinin A-receptor antagonist does not reduce satiation by endogenous CCK.
Brenner LA; Ritter RC
Physiol Behav; 1998 Feb; 63(4):711-6. PubMed ID: 9523920
[TBL] [Abstract][Full Text] [Related]
20. Postprandial neuronal activation in the nucleus of the solitary tract is partly mediated by CCK-A receptors.
Glatzle J; Kreis ME; Kawano K; Raybould HE; Zittel TT
Am J Physiol Regul Integr Comp Physiol; 2001 Jul; 281(1):R222-9. PubMed ID: 11404297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
